-+ 0.00%
-+ 0.00%
-+ 0.00%

PARABILIS MEDICINES INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $40

Reuters·07/06/2026 10:53:33

Please log in to view news